by Dean

Share

Share

For years, many financial institutions treated their Anti-Money Laundering and Countering the Financing of Terrorism (AML/CFT) frameworks as a set-and-forget exercise. The Enterprise-Wide Risk Assessment (EWRA) was refreshed annually, names were run through a screening database, and the compliance function moved on.

The latest amendments to the MAS AML/CFT Notices, which officially took effect on 1 July 2025, completely changed the basis of that assumption. The regulatory direction is consistent: template-driven compliance is no longer sufficient, and supervisory attention has aggressively shifted from what your policies say to whether your operations actually execute them.

If your compliance manual predates the July 2025 amendments, it is fundamentally exposed. These are the critical operational gaps you must close immediately.

📌 Key Takeaways: 2025 MAS AML/CFT Amendments

  • Strict STR Timelines: Suspicious Transaction Reports (STRs) must now be filed within 5 business days (or 1 business day for sanctions/proliferation financing).
  • Proliferation Financing (PF): PF is now a mandatory, distinct risk factor that must be integrated into your EWRA.
  • Native-Language Screening: AML screening must include local-language media and region-specific sources to combat transliteration gaps.
  • Expanded Trust Definitions: Trust Relevant Parties (TRPs) now legally include “protectors,” “objects of a power,” and “class of beneficiaries.”

Which Sector-Specific MAS Notice Applies to Your Firm?

MAS AML/CFT Notices are sector-specific. While the July 2025 amendments run in parallel across the financial ecosystem, the legal obligations you are held to reside exclusively within your specific instrument. Ensure your policies cite the correct notice:

Entity TypeRelevant MAS Notice
Banks & Merchant BanksNotice 626 / Notice 1014
Capital Markets Intermediaries (CMSL / LFMC / VCFM)Notice SFA04-N02
Payment Service Providers (MPI / SPI)Notice PSN01
Licensed Trust CompaniesNotice TCA-N03
Variable Capital Companies (VCC)Notice VCC-N01

How Must You Integrate Proliferation Financing (PF) into Your EWRA?

Proliferation financing—the funding of nuclear, chemical, or biological weapons proliferation—was historically treated as a minor sub-item under sanctions screening. The 2025 amendments explicitly require FIs to integrate PF risks into their AML/CFT frameworks as a standalone, distinct risk assessment.

Compliance professional updating an AML/CFT manual to meet the 2025 MAS Notice amendments in Singapore

Stating “We screen against UN sanctions lists” is no longer an adequate account of your PF controls. Your EWRA must formally document how the firm evaluates:

  • Geographic Exposure: Clients, counterparties, and transactions connected to jurisdictions of proliferation concern.
  • Dual-Use Goods: Highly relevant where trade finance or supply-chain flows are involved.
  • Corporate Structure Complexity: Layered ownership, nominee arrangements, and front companies used to actively evade PF sanctions.
  • Indirect Exposure: How PF risk reaches the firm even when clients do not deal in physical goods.
⚠️ The Asset Manager Blindspot: A fund manager with zero trade finance exposure still needs a documented assessment explaining how PF risk was considered and why the conclusion is what it is. An assessment concluding “low exposure” is perfectly acceptable; having no assessment is a regulatory breach.

Is Native-Language Screening Now a Strict MAS Expectation?

Historically, financial institutions screened English transliterations of client names. Name-matching algorithms frequently miss adverse media and sanctions hits when a name has been transliterated from Chinese, Arabic, Cyrillic, or other non-Latin scripts. Because transliteration is not standardised, the exact same individual can yield a dozen different English spellings.

The amended MAS Guidelines directly target this vulnerability. Screening must now include local-language media and region-specific sources.

For clients originating from non-English-speaking jurisdictions—particularly higher-risk entities and High-Net-Worth Individuals (HNWIs)—screening must execute searches in the client’s native script, backed by a documented audit trail detailing the exact parameters searched and the results found. An analyst who executes a native-language search but records nothing has, for MAS review purposes, failed to perform the search entirely.

Is Your AML/CFT Manual Exposing You to Fines?

Don’t wait for a MAS inspection to discover your EWRA lacks PF integration or strict STR timelines. Partner with Alder to overhaul your compliance framework to the new 2025 standards.

Book a Compliance Policy Audit

What Are the New Strict Timelines for Filing Suspicious Transaction Reports (STRs)?

The legal obligation to file an STR under the Corruption, Drug Trafficking and Other Serious Crimes (Confiscation of Benefits) Act (CDSA) demands filing “as soon as is reasonably practicable.” Previously, because the CDSA lacked a fixed day count, internal deliberations at FIs frequently dragged on for weeks.

The 2025 MAS updates completely closed this escalation gap by imposing hard deadlines in the guidelines:

  • Standard STRs: Must be filed no later than 5 business days after suspicion is established.
  • Sanctions/PF STRs: Cases involving sanctioned parties or proliferation financing must be filed no later than 1 business day after suspicion is established.

Your AML/CFT framework must explicitly map this rapid escalation pathway: Frontline Red Flag → Internal Escalation → Assessment → Decision → STRO Filing. A case sitting in an inbox between business units because nobody “owns” the decision will instantly breach the 5-day rule.

Practical measure: Mandate that your compliance team logs the exact date, time, and rationale the moment an internal alert is escalated. To see how these deadlines integrate practically, read our full STR filing guide for Singapore fund managers.

How Have Source of Wealth Checks Changed for Complex Trust Structures?

For licensed trust companies, family offices, and wealth managers, the amendments broadened due diligence requirements around complex legal arrangements.

The MAS Notice (e.g., TCA-N03) significantly expanded the legal definition of a “Trust Relevant Party” (TRP) to include:

  • The Protector
  • The Class of Beneficiaries
  • An “Object of a Power”
  • Any natural person exercising ultimate effective control over the legal arrangement.

Where a higher-risk TRP contributes assets to an arrangement, Source of Wealth (SoW) and Source of Funds (SoF) must be independently corroborated—not merely accepted on a self-declaration form. Robust corroboration requires historical tax filings, audited financials, contracts of sale, or probate records. MAS enforcement actions have repeatedly targeted lapses in transaction monitoring where analysts gathered information, noticed an SoW discrepancy, and failed to escalate it. (Review recent MAS enforcement trends to see how heavily regulators penalize un-corroborated wealth.)

What Practical Implementation Sequence Should Compliance Teams Follow?

Every one of these changes points to the same regulatory reality: Auditability. It is not enough to rewrite the policy; the policy must be evidenced in daily operations. Lean compliance functions should execute this exact sequence:

  1. Health Check: Review your current framework against the specific July 2025 amended notice applicable to your firm.
  2. Update the EWRA: Ensure PF is distinctly mapped and assessed. If PF is absent from your EWRA, it will not exist in your downstream controls.
  3. Fix the Screening Trail: Mandate that analysts log what script was searched, in what native language, against which regional sources, and the precise outcome.
  4. Map the STR Clock: Implement hard 5-day (and 1-day) escalation SLAs with named owners and documented decisions, including formal logs for decisions not to file.
  5. Strengthen SoW Corroboration: Ban self-declarations for higher-risk clients and enforce independent document gathering for all expanded Trust Relevant Parties.
  6. Train and Record: Frontline staff raise the initial red flags. If they do not recognize a PF indicator or a complex trust concern, downstream compliance cannot compensate. Record the training attendance.

Frequently Asked Questions (FAQ)

When did the MAS AML/CFT amendments take effect?

The finalised amendments and guidelines aligning MAS rules with global FATF standards officially came into effect across the financial sector on 1 July 2025.

Does my firm need to assess Proliferation Financing (PF) if we don’t touch trade finance?

Yes. You must complete and document a standalone PF assessment. Concluding that your PF exposure is low (due to a lack of trade finance) is a legitimate regulatory outcome—but entirely skipping the assessment is a breach.

Is there a strict deadline for filing an STR?

Yes. While the CDSA relies on “as soon as reasonably practicable,” MAS guidelines now strictly clarify that STRs must be filed no later than 5 business days after suspicion is established, or 1 business day for sanctions and PF cases.

Do we need native-language screening for every single client?

Screening must be proportionate to risk. However, for higher-risk clients from non-English-speaking jurisdictions, native-language and native-script searches are now an explicit regulatory expectation to address transliteration failures.

Which AML/CFT notice applies to a CMS Licence holder?

Capital Markets Intermediaries (including LFMCs and VCFMs) are governed primarily by MAS Notice SFA04-N02.

How Can Alder Assist Your Firm’s AML/CFT Overhaul?

Adapting your enterprise frameworks to the July 2025 amendments is a heavy lift for lean compliance teams. Alder translates these dense regulatory requirements into actionable, audit-ready workflows.

Our outsourced compliance specialists assist financial institutions by:

  • Conducting precise AML/CFT health checks against the exact MAS notice applicable to your licence.
  • Executing EWRA reviews and complete rewrites, including comprehensive PF risk integration.
  • Designing new native-language screening procedures and quality assurance controls.
  • Structuring rapid STR escalation frameworks to guarantee adherence to the 5-day rule.
  • Implementing bulletproof Source of Wealth corroboration methodologies for complex trust structures.

Don’t Wait for an Inspection to Test Your Framework

If your compliance manual has not been overhauled since the July 2025 amendments, you are operating at significant regulatory risk. Contact Alder to initiate an immediate compliance review.

Contact Alder Compliance Today

Disclaimer: This article is for general informational purposes only and does not constitute formal legal or regulatory advice. For guidance tailored to your specific AML/CFT obligations, consult Alder Compliance.

About the Author: Dean

Dean is the Co-Founder of Alder. An IBF Scholar, he holds a Bachelor of Business (Banking & Finance) from Nanyang Technological University. With 20+ years of regional B2B sales and marketing experience across banking, finance, technology, and professional services, he leads Alder’s business development and client relationships, supporting companies with practical outsourced compliance solutions.